Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Int J Med Robot. 2010 Sep;6(3):330-3. doi: 10.1002/rcs.339.
The initial experience of a gynaecological oncology robotic surgery programme at a tertiary care cancer centre is described.
A retrospective study was performed to evaluate the perioperative outcomes of 76 patients offered robot-assisted surgery.
Seventy-three patients underwent robot-assisted surgery; three cases were converted to laparotomy; 51% of patients underwent treatment for endometrial cancer; 18% had ovarian cancer risk reduction surgery; and 8% were treated for uterine leiomyomata. Median body mass index (BMI) was 30. Median estimated blood loss, operative time, and length of stay were 150 ml, 195 min and 1 day, respectively. The total major complication rate was 6.8% and the total minor complication rate was 15.1%.
Robot-assisted surgery is safe and appropriate for gynaecological patients undergoing surgical management. A gynaecological oncology robot-assisted programme can be easily established in a tertiary care cancer centre.
描述了一家三级癌症中心妇科肿瘤机器人手术项目的初步经验。
进行了一项回顾性研究，以评估 76 名接受机器人辅助手术的患者的围手术期结果。
73 名患者接受了机器人辅助手术；3 例转为剖腹手术；51%的患者接受了子宫内膜癌治疗；18%的患者接受了卵巢癌风险降低手术；8%的患者接受了子宫肌瘤治疗。中位数体质指数（BMI）为 30。中位数估计出血量、手术时间和住院时间分别为 150 毫升、195 分钟和 1 天。总的主要并发症发生率为 6.8%，总的小并发症发生率为 15.1%。
机器人辅助手术对于接受手术治疗的妇科患者是安全且合适的。三级癌症中心可以轻松建立妇科肿瘤机器人辅助计划。
